Biohit Oyj: Notice pursuant to the Finnish Securities Market Act, Chapter 9, Section 10


Biohit Oyj: Notice pursuant to the Finnish Securities Markets Act, Chapter 9, Section 10

Biohit Oyj
STOCK EXCHANGE RELEASE
June 8, 2018 at 3.40 PM

Biohit Oyj: Notice pursuant to the Finnish Securities Market Act, Chapter 9, Section 10

Biohit Oyj has received an announcement from Osmo Suovaniemi on June 8, 2018 in accordance with the Finnish Securities Market Act Chapter 9, Section 5.

According to the announcement, the total number of Biohit Oyj shares owned by Osmo Suovaniemi has decreased below fifteen (15) per cent of the share capital of Biohit Oyj on June 8, 2018.

Total positions of Osmo Suovaniemi according to the notification:

 % of shares and voting rights

 
% of shares and voting rights through financial instruments

 
Total of both in %Total number of shares and voting rights of issuer
Resulting situation on the date on which the threshold was crossed or reached13,56 % shares and 56,52 % votes  14 889 278 shares and
71 423 778 votes
Position of previous notification (if applicable)34,76 % shares and 68,43 5 votes   

Notified details of the resulting situation on the date on which the threshold was crossed or reached:

A: shares and voting rights:

Class / type of shares
ISIN-code
Number of shares and voting rights % of shares and voting rights
Direct
(SMA 9:5)
Indirect
(SMA 9:6 and 9:7)
Direct
(SMA 9:5)
Indirect
(SMA 9:6 ja 9:7)
FI0009005482000%0%
A-shares2 018 310 shares and
40 366 200 votes
 13,56 % shares and 56,52 % votes 
     
SUBTOTAL A2 018 310 shares and
40 366 200 votes
13,56 % shares and
56,52 % votes

B: Financial instruments according to SMA 9:6a

Type of Financial instrument Expiration date Exercise / Conversion period Physical or cash settlement  Number of shares and voting rights% of shares and voting rights
      
      
      
 SUBTOTAL B  

Information on the party obliged to give notice of major shareholding:

Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entity:

Name% of shares and voting rights % of shares and voting rights through financial instruments Total of both
Osmo Suovaniemi13,56 % shares and
56,52 % votes
 2 018 310 shares and
40 366 200 votes
Interlab Oy0 0

More information:
CEO Semi Korpela, Biohit Oyj
tel. +358 9 773 861
investor.relations@biohit.fi, www.biohit .fi

Biohit Oyj in brief

Biohit Oyj is a Finnish biotechnology company operating on a global scale. Biohit’s mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit’s headquarters are located in Helsinki with subsidiaries in Italy and the UK.